Neoadjuvant PD-1 Blockade Boosts pCR Rates in Early Esophageal Cancer
(MedPage Today) -- SAN FRANCISCO -- Adding an investigational PD-1 inhibitor to chemotherapy in the neoadjuvant setting significantly improved pathological complete response (pCR) rates for patients with resectable locally advanced esophageal... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 22, 2024 Category: Hematology Source Type: news
Increase in Congenital Syphilis; Decrease in Breast Cancer Mortality
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 20, 2024 Category: Hematology Source Type: news
Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer
(MedPage Today) -- While cancer mortality continues to decline, the number of new cases is projected to top 2 million in 2024, according to the American Cancer Society's annual report on cancer statistics.
The FDA approved exagamglogene autotemcel... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 19, 2024 Category: Hematology Source Type: news
Kate Middleton Hospitalized; Sen. Paul Urges Prison for Fauci; COVID Back in Class
(MedPage Today) -- Note that some links may require registration or subscription.
Kate Middleton, the Princess of Wales, has been hospitalized following a planned abdominal surgery at a London clinic and canceled all engagements until Easter... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 17, 2024 Category: Hematology Source Type: news
Breast Cancer Mortality Reduced by 58% Over Past Four Decades
(MedPage Today) -- Breast cancer screening and new treatments were associated with a large reduction in mortality from the disease over the past 45 years, according to results from a simulation model-based study.
Using four models, the combination... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 16, 2024 Category: Hematology Source Type: news
EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk
(MedPage Today) -- Patients with lung cancer treated with epidermal growth factor receptor (EGFR) inhibitors may have an increased risk of new-onset keratitis, a U.S. population-based cohort study showed.
Over a 20-year period, 1.12% of patients... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 13, 2024 Category: Hematology Source Type: news
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA
(MedPage Today) -- A number of common cancers associated with high mortality and cancers more likely to affect Black patients receive disproportionate funding for research and advocacy. (Journal of Clinical Oncology)
The FDA declined to approve... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 12, 2024 Category: Hematology Source Type: news
COVID Vax and Blood Clots; Cancer Rise in Young Adults; Corpse-Abuse Charge Dropped
(MedPage Today) -- Note that some links may require registration or subscription.
In observance of Martin Luther King Day, Morning Break will not be published January 15 and will resume Tuesday January 16.
Last year's COVID-19 booster reduced... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 12, 2024 Category: Hematology Source Type: news
Exercise Improved Quality of Life for Metastatic Breast Cancer Patients
(MedPage Today) -- Among patients with metastatic breast cancer, those who took part in a 9-month structured exercise program reported less fatigue and improved quality of life compared with patients receiving usual care, results from the PREFERABLE... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 12, 2024 Category: Hematology Source Type: news
No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy
(MedPage Today) -- Patient-adjusted nitrous oxide (N2O), commonly called laughing gas, did not reduce anxiety associated with transrectal prostate biopsy but significantly reduced pain as compared with standard anesthesia, a small randomized study... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 12, 2024 Category: Hematology Source Type: news
Hypofractionated Chemoradiation With Adaptive SABR Appeared Effective in NSCLC
(MedPage Today) -- A dose-escalation strategy involving hypofractionated concurrent chemoradiation with adaptive stereotactic ablative radiotherapy (SABR) appeared safe and effective for patients with locally advanced non-small cell lung cancer... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 12, 2024 Category: Hematology Source Type: news
Pirtobrutinib Shows Potential in Heavily Pretreated Follicular Lymphoma
(MedPage Today) -- Treatment with single-agent pirtobrutinib (Jaypirca), a non-covalent Bruton's tyrosine kinase (BTK) inhibitor, showed encouraging efficacy with a tolerable safety profile in a cohort of heavily pretreated patients with relapsed... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 11, 2024 Category: Hematology Source Type: news
Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T
(MedPage Today) -- A phase Ib/II study demonstrated that mosunetuzumab (Lunsumio) plus polatuzumab vedotin (Polivy) induced durable responses in patients with relapsed or refractory large B-cell lymphoma (LBCL), including patients who relapsed... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 11, 2024 Category: Hematology Source Type: news
Carvedilol No Help in Preventing Heart Failure in Childhood Cancer Survivors
(MedPage Today) -- The use of low-dose carvedilol did not significantly improve certain cardiac measures of heart failure risk in long-term survivors of childhood cancer exposed to anthracycline compared with placebo, the randomized phase IIb PREVENT... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 10, 2024 Category: Hematology Source Type: news
Cryobiopsy and Forceps Biopsy Go Head-to-Head for Diagnosing Lung Lesions
(MedPage Today) -- As a supplement to standard needle aspiration for diagnosing lung lesions, cryobiopsy was no better than forceps biopsy for producing a definite diagnosis in a randomized trial, but the tissue-freezing procedure was less time... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 10, 2024 Category: Hematology Source Type: news
